Core Viewpoint - The Pacer US Small Cap Cash Cows ETF (CALF) is a smart beta ETF that targets small-cap value stocks with high free cash flow yields, aiming to outperform traditional market cap weighted indexes [1][5]. Fund Overview - CALF was launched on June 16, 2017, and has accumulated over $4.32 billion in assets, positioning it as one of the larger ETFs in the small-cap value category [1][5]. - The ETF seeks to match the performance of the Pacer US Small Cap Cash Cows Index, which employs a rules-based methodology [5]. Cost Structure - The annual operating expenses for CALF are 0.59%, which is relatively high compared to other products in the space [6]. - The fund has a 12-month trailing dividend yield of 1.04% [6]. Sector Exposure and Holdings - The ETF has a significant allocation in the Industrials sector, comprising approximately 21.9% of the portfolio, followed by Consumer Discretionary and Information Technology [7]. - The top holding, Cf Industries Holdings Inc, accounts for about 2.31% of total assets, with the top 10 holdings representing around 20.38% of CALF's total assets [8]. Performance Metrics - As of July 11, 2025, CALF has experienced a year-to-date loss of approximately -4.85% and a decline of about -0.79% over the past year [10]. - The ETF has traded between $32.00 and $48.76 in the past 52 weeks, with a beta of 1.09 and a standard deviation of 23.22% over the trailing three-year period [10]. Alternatives - Other ETFs in the small-cap value space include iShares Russell 2000 Value ETF (IWN) and Vanguard Small-Cap Value ETF (VBR), which have lower expense ratios and larger asset bases [12].

Group 1 - The company experienced a significant decline during the pandemic but is projected to recover and exceed previous figures by 2024, with current revenue nearing $3 billion and healthy cash flow [1] - The analysis approach focuses on triangulation between valuation by multiples, discounted cash flow (DCF), and dividend yield, emphasizing a bottom-up methodology [1] - The company prioritizes smaller capitalization stocks in the Consumer Discretionary and Consumer Staples sectors, where there is greater potential for asymmetries and alpha generation [1] Group 2 - The investment philosophy combines income and value investing strategies, requiring an adequate margin of safety in multiples and projected cash flow [1] - Dividend yield is considered a fundamental component for generating returns and mitigating risks, especially in low coverage stocks [1] - The analysis aims to produce in-depth, rational, data-driven insights to support informed investment decisions [1]

Core Viewpoint - MTY Food Group Inc. reported its financial results for Q2 2025, highlighting a mixed performance across its geographical segments, with challenges in the U.S. market contrasted by strong results in Canada. The company is implementing strategic initiatives to enhance guest experiences and improve profitability in its Corporate segment [2][3][18]. Financial Highlights - Revenue for Q2 2025 was $304.9 million, slightly up from $303.7 million in Q2 2024 [4][11]. - Adjusted EBITDA for Q2 2025 decreased to $69.3 million from $73.2 million in Q2 2024, while normalized adjusted EBITDA was $70.0 million, down from $73.7 million [4][11]. - Net income attributable to owners increased significantly to $57.3 million, or $2.49 per diluted share, compared to $27.3 million, or $1.13 per diluted share in Q2 2024 [4][11]. - Cash flows from operations were $40.2 million, a slight decrease from $40.6 million in Q2 2024 [4][18]. - Free cash flows net of lease payments were $23.6 million, down from $24.3 million in Q2 2024, but per diluted share increased to $1.03 from $1.01 [4][11]. Segment Performance - The franchise segment's normalized adjusted EBITDA increased by 3% to $54.0 million, while the Corporate segment saw a decline in normalized adjusted EBITDA to $11.3 million, down $5.5 million year-over-year [4][11][12]. - System sales for Q2 2025 reached $1.46 billion, a modest increase of 0.3% compared to Q2 2024, with a 1% decrease in the U.S. segment offset by a 3% growth in Canada [5][11]. - Same-store sales decreased by 1.9% year-over-year, with Canada growing by 1.4% and the U.S. declining by 3.8% [11][12]. Operational Insights - As of the end of Q2 2025, MTY operated 7,046 locations, with a stable geographical split of 57% in the U.S., 35% in Canada, and 8% internationally [11][19]. - The company opened 76 new locations during the quarter but closed 77, resulting in a net decrease of one location [11][19]. - Digital sales increased by 3% to $296.7 million compared to $287.7 million in Q2 2024 [5][11]. Dividend Declaration - MTY declared a quarterly dividend of $0.33 per share, payable on August 15, 2025, to shareholders registered by August 5, 2025 [2][15].

Core Viewpoint - Harmonic AI, co-founded by Vlad Tenev and Tudor Achim, aims to develop an AI system capable of solving complex mathematical problems, striving for Mathematical Superintelligence (MSI) [3][20]. Group 1: Company Overview - Harmonic AI has successfully raised $100 million in Series B funding, bringing its valuation to approximately $875 million [4][17]. - The company was co-founded by Vlad Tenev, who previously established Robinhood Markets, and Tudor Achim, an expert in AI and large model training [5][15]. - Robinhood, under Tenev's leadership, achieved a market cap of around $22.7 billion and reported a revenue of $927 million with a net profit of $336 million in Q1 2025 [8][12]. Group 2: Funding and Valuation - Harmonic AI's Series A funding raised $75 million, led by Sequoia Capital, with a post-money valuation of $325 million [15]. - The recent Series B funding was led by Kleiner Perkins, with participation from Paradigm and Ribbit Capital, among others [16]. - The company intentionally set its valuation below the "unicorn" threshold of $1 billion, focusing on long-term growth rather than short-term valuation targets [18][19]. Group 3: Product Development - Harmonic AI announced its first model, Aristotle, which can formalize natural language problems into formal representations, enhancing collaboration with mathematicians [20]. - The model's performance improved from 83% to 90% on the MiniF2F benchmark, which includes various levels of mathematical problems [23]. - The ultimate goal is to create an AI system with mathematical capabilities surpassing human abilities, addressing challenges like the "hallucination" problem in AI [26][28].

RT Uché Perkins Sr. (@JustAFamilyMan_)I have turned a leaf with this account and it will mainly be focused on building generational wealth and family oriented themes. https://t.co/lsHW8sqmGa ...

Investment Rating - The report maintains a "Buy" rating for Lingyi, with a 12-month price target of Rmb11.40, indicating an upside potential of 28.1% from the current price of Rmb8.90 [18][13]. Core Insights - Lingyi's revenues are expected to grow by 23% year-over-year in 2Q25, reaching Rmb11.5 billion, driven by new project contributions and improved seasonality in the second half of 2025 [1][3]. - The gross margin (GM) is projected to improve to 15.7% in 2Q25, up from 15.2% in 1Q25, although still below the 2022/2023 levels of 20.7% and 19.9% respectively [1][3]. - Lingyi's diversification into foldable phones, servers, and AI/AR glasses components is expected to increase revenue contributions to 14% and 18% in 2025 and 2026 respectively [1][2]. Revenue and Earnings Estimates - Revenue estimates for 2025 remain unchanged at Rmb54.5 billion, with net income expected to grow by 43% year-over-year [3][9]. - Earnings revisions indicate a decrease in net income estimates by 11% for 2025, primarily due to lower GM from the automotive and server segments [3][7]. - The report anticipates a compound annual growth rate (CAGR) of 21% in revenues from 2025 to 2027 [3][9]. Financial Metrics - The report projects gross margins to expand from 15.8% in 2024 to 16.6% and 18.2% in 2025 and 2026 respectively [3][11]. - Operating profit margins (OPM) are expected to improve from 6.0% in 2025 to 8.1% in 2027 [3][11]. - The net margin is forecasted to increase to 4.6% and 5.7% in 2025 and 2026 respectively [3][11]. Market Position and Competitive Landscape - Lingyi is expanding its business in foldable phones, servers, robotics, and AI/AR glasses components to reduce concentration risk and capture a larger market share [2][3]. - The company has established partnerships to provide comprehensive manufacturing solutions, which are expected to lower the bill of materials (BOM) costs for clients [2][3]. Valuation - The target price of Rmb11.4 is based on a target P/E multiple of 21.2x 2026E EPS, reflecting a positive correlation between P/E and EPS growth among peers [11][17]. - Lingyi is currently trading at a P/E of 17x for 2026E, which is considered attractive [13][17].

🚨 ALERT: $650,000,000 worth of crypto positions liquidated in 1 hour. https://t.co/BuSRu3ucqE ...

Identity Verification & Security - Clear emphasizes the increasing importance of trusted and witnessed identity in an AI-driven world with synthetic identities [1] - Clear partners with companies like Greenhouse to ensure identity integrity of applicants, addressing concerns about workforce infiltration [1] - Clear's technology is used for workforce identification, as seen in the partnership with T-Mobile, enhancing workforce security and asset protection [3][4] - Clear partners with Octa to provide a more powerful authentication and access product for the workforce [6] - Clear believes that ubiquitous identity verification is essential for companies dealing with sensitive information or IP [7] Technology & AI Integration - Clear utilizes AI in various workstreams, including legal, finance, HR, and operations [1] - Clear's technology aims to drive efficiency and automation in identity verification processes [5] Market Opportunity & Expansion - The addressable market for trusted identity solutions is massive, both in the US and globally [2] - Clear is expanding into healthcare, partnering with Epic to provide a seamless way for patients to access their data [14] Travel Industry - Clear sees strong secular demand for travel and aims to improve the day of travel experience for consumers [11] - Clear announced a concierge product in its mobile app to assist travelers at the airport [13] Privacy & Trust - Clear prioritizes being a trusted brand with privacy policies that give consumers control over their data [9] - Clear addresses concerns about facial scanning by focusing on transparency and user control over data [9] Public-Private Partnerships - The company acknowledges the Trump administration's support for public-private partnerships, which has benefited Clear's growth [15]

Core Points - Crinetics Pharmaceuticals granted non-qualified stock option awards for 102,350 shares and restricted stock unit (RSU) awards for 77,875 shares to 46 new non-executive employees as part of the 2021 Employment Inducement Incentive Award Plan [1][2] - The stock options have an exercise price of $31.99 per share, equal to the closing price on July 10, 2025, and will vest over four years [2] - Crinetics Pharmaceuticals is focused on developing novel therapeutics for endocrine diseases and related tumors, with lead candidate paltusotine in clinical development for acromegaly and carcinoid syndrome [3] Summary by Category Stock Options and RSUs - The stock options and RSUs were granted as inducements for new employees under the 2021 Inducement Plan, in compliance with Nasdaq Listing Rule 5635(c)(4) [1][2] - Stock options will vest 25% after one year, with the remainder vesting in 36 equal monthly installments, contingent on continued employment [2] - RSUs will vest in equal annual installments over four years, also dependent on continued employment [2] Company Overview - Crinetics Pharmaceuticals is a clinical stage pharmaceutical company specializing in endocrine diseases and tumors [3] - The company’s lead candidate, paltusotine, is the first investigational oral selective somatostatin receptor type 2 nonpeptide agonist [3] - Other drug candidates in development include treatments for congenital adrenal hyperplasia and ACTH-dependent Cushing's syndrome, with a focus on orally delivered small molecules [3]

Core Insights - Nebius Group N.V. is experiencing significant growth in the AI cloud market, with a reported 385% year-over-year revenue increase in Q1 2025, reaching $55.3 million [2][3] - The company has a strong Buy consensus rating from Wall Street analysts, indicating that the market has not fully recognized its potential, with a 12-month price target of $66.50, representing a 41.85% upside from the current price [11][12] Financial Performance - Nebius's Annualized Recurring Revenue (ARR) has surged to $310 million by April 2025, reflecting a stable and growing customer base, supporting management's revenue guidance of $500 million to $700 million for the full year [3] - Management anticipates reaching adjusted EBITDA break-even in the second half of 2025, which would signify a de-risking event for the stock [4] Competitive Advantage - Nebius differentiates itself in the crowded cloud market by offering a full-stack platform that optimizes the entire technology pipeline, from hardware design to proprietary software management [5][6] - The company's platform is specifically designed to handle the intensive data processing needs of AI models, avoiding bottlenecks common in general-purpose clouds [7] Strategic Partnerships and Investments - Nebius has established key industry partnerships, including being a launch partner for NVIDIA's latest chips, providing clients with early access to advanced AI hardware [8] - The company secured a $1 billion convertible note offering to fund its expansion and data center growth, ensuring it can meet increasing customer demand [9] Market Validation - A strategic investment in Nebius's Toloka business by Bezos Expeditions, led by Amazon founder Jeff Bezos, enhances the company's credibility and may attract further investment [10] Valuation and Future Outlook - Analysts maintain a strong Buy rating for Nebius, with an average price target of $66.50 per share, indicating optimism about the company's future growth and profitability [11][12] - The stock is viewed as potentially undervalued, with analysts suggesting that as Nebius executes its growth strategy, its stock price will be adjusted to reflect its role in the AI ecosystem [12][13]